SEARCH

SEARCH BY CITATION

References

  • 1
    Wenzel RP, Edmond MB. Managing antibiotic resistance. N. Engl. J. Med. 2000; 343: 19611963.
  • 2
    Montini G, Tullus K, Hewitt I. Febrile urinary tract infections in children. N. Engl. J. Med. 2011; 365: 239250.
  • 3
    Chen LF, Chopra T, Kaye KS. Pathogens resistant to antimicrobial agents. Infect. Dis. Clin. North Am. 2009; 23: 817845.
  • 4
    Hague R. What is the threat from extended spectrum β-lactamaze-producing organisms in children? Arch. Dis. Child. 2011; 96: 325327.
  • 5
    Overturf GD. Carbapenemnases: a brief review for pediatric infectious disease specialist. Pediatr. Infect. Dis. J. 2010; 29: 6870.
  • 6
    Normark BH, Normark S. Evolution and spread of antibiotic resistance. J. Intern. Med. 2002; 252: 91106.
  • 7
    Chavez-Bueno S, Stull TL. Antibacterial agents in children. Infect. Dis. Clin. North Am. 2009; 23: 865880.
  • 8
    Carrillo-Marquez MA, Hulten KG, Hammerman W, Lamberth L, Mason EO, Kaplan SL. Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. Pediatr. Infect. Dis. J. 2011; 30: 545550.
  • 9
    Martinez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus in children. Pediatr. Infect. Dis. J. 2011; 22: 593598.
  • 10
    Sievent DM, Rudrick JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the Unites States, 2002–2006. Clin. Infect. Dis. 2008; 46: 668674.
  • 11
    Walsh TR, Toleman MA. The emergence of pan-resistant gram-negative pathogens merits a rapid global political response. J. Antimicrobial. Chemother. 2012; 67: 13.
  • 12
    Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin. Infect. Dis. 2011; 53: 6067.
  • 13
    Perez F, Hujer AM, Hujer KM, Decker BK, Rather ON, Bonomo RA. Global challenge of multi-drug resistant Acinetobacter baumani. Antimicrobial. Agents Chemother. 2007; 51: 34713484.
  • 14
    Nordmann P, Poirel L, Toleman MA, Walsh TR. Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J. Antimicrobial. Chemother. 2011; 66: 689692.
  • 15
    Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: a molecular, biological and epidemiological study. Lancet Infect. Dis. 2010; 10: 597602.
  • 16
    Castanheira M, Mendes RE, Woosley LN, Jones RN. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007–09). J. Antimicrobial. Chemother. 2011; 66: 14091411.
  • 17
    Paterson DL. Impact of antibiotic resistance in Gram-negative bacilli on empirical and definitive antibiotic therapy. Clin. Infect. Dis. 2008; 47 (Suppl. 1): 1420.
  • 18
    Jones RN. Microbiological features of vancomycin in the 21st century: MIC creep, bactericidal/static activity and applied breakpoints to predict outcomes or detect resistant strains. Clin. Infect. Dis. 2006; 42 (Suppl. 1): S1324.
  • 19
    Blaser M. Antibiotic overuse: stop the killing of beneficial bacteria. Nature 2011; 476: 393394.
  • 20
    Pennisi E. Girth and the gut bacteria. Science 2011; 332: 3233.
  • 21
    British Society for Antimicrobial Chemotherapy. The urgent need for new antimicrobial agents. J. Antimicrobial. Chemother. 2011; 66: 19391940.
  • 22
    Dryden M, Johnson AP, Ashiru-Oredope D, Sharland M. Using antibiotics responsively: right drug, right time, right dose, right duration. J. Antimicrobial. Chemother. 2011; 66: 24412443.
  • 23
    Liu C, Bayer A, Cosgrove SE et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 2011; 52: 285292.
  • 24
    Schwaber MJ, Lev B, Israeli A et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin. Infect. Dis. 2011; 52: 848855.
  • 25
    Saeidi N, Wong CK, Lo TM et al. Engineering microbes to sense and eradicate Pseudomonas aeruginosa, a human pathogen. Mol. Syst. Biol. 2011; 7: 521532.